Loading...
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
BACKGROUND: Tofacitinib is an oral, small molecule JAK inhibitor for the treatment of ulcerative colitis (UC). AIM: To report incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in the tofacitinib UC programme. METHODS: DVT and PE were evaluated from one phase 2 and two phase 3 induc...
Na minha lista:
| Udgivet i: | Aliment Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899755/ https://ncbi.nlm.nih.gov/pubmed/31599001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.15514 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|